微乳液中球形及棒状SrTiO3纳米粒子的控制合成

以氢氧化锶和钛酸四丁酯为原料, 在水溶液/Triton X-100/环己烷/正己醇反相微乳液体系中制备了直径约为20～80 nm的钛酸锶球形纳米粒子和长约300～1200 nm、直径约为30～150 nm的钛酸锶纳米棒. 用XRD, ICP, TEM, SAED和SEM对样品的结构、成分和形貌进行了表征; 用DLS分析了样品的粒度分布. 结果显示, 水与表面活性剂的物质的量比(ω₀)、反应物浓度、陈化时间等因素都能影响钛酸锶纳米粒子的形貌和尺寸. 所得钛酸锶的锶钛物质的量比约为1.0, 粒度分布较窄, 为立方相单晶结构.     

Mesoporous materials for drug delivery

Research on mesoporous materials for biomedical purposes has experienced an outstanding increase during recent years. Since 2001, when MCM-41 was first proposed as drug-delivery system, silica-based materials, such as SBA-15 or MCM-48, and some metal-organic frameworks have been discussed as drug carriers and controlled-release systems. Mesoporous materials are intended for both systemic-delivery systems and implantable local-delivery devices. The latter application provides very promising possibilities in the field of bone-tissue repair because of the excellent behavior of these materials as bioceramics. This Minireview deals with the advances in this field by the control of the textural parameters, surface functionalization, and the synthesis of sophisticated stimuli-response systems.     

Combined effect of chemically compound graphene oxide‐calcium pimelate on crystallization behavior,morphology and mechanical properties of isotactic polypropylene

The combined nucleation effect of graphene oxide (GO) and calcium pimelate (CaPi) which are chemically compound together (expressed in GO ? CaPi) in isotactic polypropylene (iPP) was investigated. Fourier transform infrared (FTIR), X‐ray diffraction (XRD) and thermogravimetric analysis (TGA) verified that CaPi was chemically compound with GO by chelate bonds. The crystallization behavior and crystalline morphologies of iPP nucleated with different mass ratio of GO and CaPi were investigated. The crystallization peak temperature of iPP nucleated with 0.2 wt% GO ? CaPi with the mass ratio of 1:5 (GO1 ? C5) was increased by 8.3°C when compared with that of pure iPP, and the relative content of β‐crystal reached up to 0.7962. Whereas, the crystallization peak temperature of iPP nucleated with 0.2 wt% GO and CaPi which are blended together by mechanical force (expressed in GO + CaPi) with the mass ratio of 1:5 (GO1 + C5) was only increased by 5.0°C. It was attributed to that the aggregation of GO + CaPi caused the decrease of the crystallization peak temperature, while the GO1 ? C5 uniformly dispersed in the iPP matrix. Unexpectedly, the relative content of β‐crystal of iPP nucleated with 0.02 wt% GO1 ? C5 reached up to 0.8094, and the crystallization peak temperature was increased by 6.7°C compared with that of pure iPP. Meanwhile, the impact strength, tensile strength and heat deflection temperature of iPP nucleated with 0.02 wt% GO1 ? C5 increased by almost 45.86%, 2.03% and 7.7°C, respectively. The iPP nucleated with GO1 ? C5 obtained a balance between stiffness and toughness and the thermo‐mechanical property of nucleated iPP was improved.     

温度对乙醇电催化氧化的影响

升高温度可以提高反应速率和增加物质的输运,因此通过不同温度下反应机理的研究可以深入理解电催化过程,对催化剂的设计具有指导意义。本工作初步建立了变温原位红外测定方法。采用温控电极,用电势测温法进行温度的校准,实验得出控温仪器加热温度Th与电极表面温度TS的关系为T_S=0.57T_h+7.71 (30°C T_h≤50°C);T_S=0.62T_h+5.12 (50°C T_h≤80°C),误差分析最大温差为1°C。利用该方法我们研究了商业Pt/C催化剂在不同温度下乙醇的电氧化过程。从循环伏安图可以明显看到随着温度的升高整体氧化电流增大,起始电位、峰电位均负移,说明热活化使得氧化反应更容易进行;第一个峰电流与第二个峰电流的比值用于定性评估CO_2的选择性,对比25°C,商业Pt/C催化剂在65°C下第一峰提高30%,说明高温有利于C―C键的断裂。对比25°C的原位红外谱图,我们发现35°C及50°C下商业Pt/C催化剂上CO_2产物的起始电位负移200 m V,说明高温下,Pt/C催化剂能在更低的电位提供含氧物种;而CH_3CHO、CH_3COOH起始电位不随温度变化。用CO_2与CH_3COOH的积分面积比来评估CO_2选择性,发现高温低电位其选择性最高,说明高温低电位有利于乙醇完全氧化生成CO_2,而高温高电位下表面吸附含氧物种占据了活性位,阻碍C―C键断裂。     

可控自由基聚合系列实验教学中的一些尝试与经验*

设计了基于可控自由基聚合的系列实验教学,包括:单体和引发剂精制、RAFT试剂合成、不同单体的RAFT/ATRP聚合、RAFT聚合制备嵌段聚合物、ATRP制备嵌段聚合物等。这些实验环环相扣,互相支撑,又有着明显的对比效果。这种尝试有效改进和扩充了常规高分子合成教学中的自由基聚合部分,有效激发了学生的主动性,提高了其分析问题、解决问题的能力。     

沉积温度对Cu_2O薄膜生长过程及光电性能的影响(英文)

以硫酸铜为铜源,采用一步化学浴沉积法制备出了晶粒尺寸可调的纳米晶Cu2O薄膜。通过X射线衍射、扫描电镜和紫外可见分光光度法研究了沉积温度对薄膜晶体结构、成核密度、晶粒尺寸、薄膜厚度和光电性能的影响。结果表明,当在60~90℃范围内调节温度时,能够很好地控制晶粒尺寸、薄膜厚度,并将禁带宽度控制在33~51 nm、392~556 nm和2.47~2.61 eV范围内;随着晶粒尺寸的减小,紫外可见光谱的吸收边有明显的蓝移。此外还对薄膜的生长过程,成核密度和颗粒尺寸变化的机理进行了讨论。     

Nucleation and Growth Synthesis of Siloxane Gels to Form Functional,Monodisperse, and Acoustically Programmable Particles

Nucleation and growth methods offer scalable means of synthesizing colloidal particles with precisely specified size for applications in chemical research, industry, and medicine. These methods have been used to prepare a class of silicone gel particles that display a range of programmable properties and narrow size distributions. The acoustic contrast factor of these particles in water is estimated and can be tuned such that the particles undergo acoustophoresis to either the pressure nodes or antinodes of acoustic standing waves. These particles can be synthesized to display surface functional groups that can be covalently modified for a range of bioanalytical and acoustophoretic sorting applications.     

基于碳点多功能纳米载药体系的制备及pH响应释药性能研究

采用一步微波法成功制备了表面带氨基的荧光纳米碳点CDots, 并通过酰胺化反应将靶向基团叶酸接枝到碳点表面, 成功获得中间产物CDots-FA. 在此基础上, 通过已合成四臂端酰肼基化合物2与抗肿瘤药物阿霉素(DOX)连接, 实现在碳点表面的阿霉素药物分子的化学键合, 最终获得多功能纳米载药体系DOX-CDots-FA. 利用原子力显微镜(AFM)、高分辨透射电镜(HR-TEM)和荧光光谱仪对荧光纳米碳点CDots的性能进行表征, 并通过核磁共振、紫外-可见吸收光谱对DOX-CDots-FA结构、接枝率进行了表征. 同时对纳米载药体系DOX-CDots-FA体外药物释放行为、细胞毒性及细胞摄取成像进行了系统的研究. 结果表明, DOX-CDots-FA具有良好的pH响应性. 叶酸靶向基团能加速DOX-CDots-FA被HeLa (FR+)细胞摄取, 并表现出更强的细胞毒性. 同时细胞摄入成像实验表明, 在叶酸靶向作用下, DOX-CDots-FA通过内吞作用进入HeLa细胞, 随后阿霉素被释放出来并进入细胞核区域, 抑制细胞的生长, 从而实现靶向治疗, 降低毒副作用.     

铂类抗癌药物的多功能纳米递送体系

以顺铂为代表的小分子铂类抗癌药物是临床应用的一线化疗药物,但其严重的毒副作用和难以克服的耐药性限制了铂类药物的临床应用和研发。运用纳米药物递送技术可以实现药物的靶向递送和可控释放,来提高药物的生物利用度,降低药物的毒副作用以及耐药性,为癌症的治疗带来新的希望。此外,丰富多样的纳米递送体系易于实现药物与具有生物学活性试剂的共运输,从而为各种治疗策略以及诊疗策略的联用提供可能,为最终实现癌症的精准治疗展现广阔前景。本文从靶向递药、药物可控释放、联合治疗、诊疗一体化四个方面对铂类抗癌药物的多功能纳米递送体系在癌症治疗中的最新研究进展进行综述,同时通过列举最新研究成果,展示了新材料、新技术以及新颖设计思想在铂基纳米递送体系中的应用。     

光散射法研究丙烯酸十八酯和苯乙烯微乳液 共聚机理

在十六烷基溴化吡啶/叔丁醇/15%丙烯酸十八酯和苯乙烯/水体系的O/W微乳液中,使用动态光散射法,研究其中两种单体共聚反应的成核机理。结果表明,聚合过程中乳胶粒成核位置主要在增溶胶囊的单体微珠中,乳胶粒主要依靠单体微珠不断提供单体而长大。